$HALO Recent News Amazon gains on June event;
Post# of 72722
Posted On: 09/07/2014 9:52:04 AM
$HALO Recent News
Amazon gains on June event; PVH sinks on results 3:36 p.m. June 5, 2014 - Sue Chang
Stock futures rise after ECB moves, claims report 9:00 a.m. June 5, 2014 - Barbara Kollmeyer
ECB, jobs report could finally ignite the stock-market powder keg 8:46 a.m. June 5, 2014 - Shawn Langlois
PVH falls, Halozyme, Five Below, gain after hours 4:51 p.m. June 4, 2014 - Myra P. Saefong
Rackspace shares surge after hours on earnings 6:10 p.m. May 12, 2014 - Wallace Witkowski
Halozyme temporarily halts dosing in cancer study 9:27 a.m. April 4, 2014 - MarketWatch.com
A Morgan Stanley buy, Alcoa's report and the streaker opens up 8:18 a.m. Oct. 8, 2013 - Shawn Langlois
Halozyme shares jump on Roche $10 million milestone payment 12:40 p.m. Sept. 27, 2013 - Russ Britt
Isis, Novartis, Halozyme all rise on positive product news 11:48 a.m. Sept. 3, 2013 - Russ Britt
European regulators smile on small biotech Halozyme, and shares soar 6:22 p.m. June 28, 2013 - Russ Britt
Little-noticed firm makes a splash with pancreatic cancer treatment 2:25 p.m. May 16, 2013 - Russ Britt
6 gut checks before the stock market's opening bell 6:49 a.m. March 25, 2013 - Shawn Langlois
Synageva director bought shares for trust 2:41 p.m. Jan. 17, 2013 - Insider Monkey
Friday’s biggest gaining and declining stocks 4:51 p.m. Dec. 21, 2012 - Matt Andrejczak
ViroPharma gets okay to test reformulated Cinryze 1:09 p.m. Sept. 21, 2012 - MarketWatch.com
Halozyme soars 27% on Cinryze drug update 11:51 a.m. Sept. 21, 2012 - Val Brickates Kennedy
FDA lifts temporary hold on ViroPharma treatment 8:30 a.m. Sept. 21, 2012 - MarketWatch.com
Halozyme rebounds 12% in midday trading 11:21 a.m. Aug. 3, 2012 - Val Brickates Kennedy
Halozyme rebounds 10% in morning action 10:52 a.m. Aug. 3, 2012 - Val Brickates Kennedy
Halozyme's PEGPH20 Program Gains Fast Track Designation - Analyst Blog 5:00 p.m. Sept. 5, 2014 - Zacks.com
Hottest Healthcare Stocks Now – EXAS ACHN HALO CLDX 9:00 a.m. Sept. 3, 2014 - InvestorPlace.com
Halozyme's PEGPH20 Program In Metastatic Pancreatic Cancer Receives Fast Track Designation 7:35 a.m. Sept. 3, 2014 - benzinga.com
Halozyme Gains on Narrower-than-Expected Loss, Revenues Up - Analyst Blog 10:53 a.m. Aug. 14, 2014 - Zacks.com
Halozyme Therapeutics' (HALO) CEO Helen Torley on Q2 2014 Results - Earnings Call Transcript 6:50 p.m. Aug. 11, 2014 - Seeking Alpha
10-Q: HALOZYME THERAPEUTICS INC 4:32 p.m. Aug. 11, 2014 - Edgar Online - (EDG = 10Q, 10K)
Biggest Movers in Healthcare Stocks Now – IRWD IPXL SGEN PCRX 7:30 a.m. Aug. 6, 2014 - InvestorPlace.com
2nd Half Of 2014 Biotechnology Catalysts-Part 3 2:36 p.m. Aug. 4, 2014 - Seeking Alpha
Trade-Ideas: Halozyme Therapeutics (HALO) Is Today's "Perilous Reversal" Stock 10:47 a.m. Aug. 1, 2014 - TheStreet.com
Halozyme Therapeutics Receives Favorable FDA Decision 1:45 p.m. July 31, 2014 - benzinga.com
Biggest Movers in Healthcare Stocks Now – HALO TRNX LGND 1:45 p.m. July 31, 2014 - InvestorPlace.com
Biggest Movers in Healthcare Stocks Now – UTHR HLS HALO ARIA 7:45 a.m. July 29, 2014 - InvestorPlace.com
Halozyme Announces Resumption of Patient Enrollment, Dosing in PEGPH20 Clinical Trial 8:02 a.m. July 22, 2014 - benzinga.com
Trade-Ideas: Halozyme Therapeutics (HALO) Is Today's "Perilous Reversal" Stock 9:57 a.m. July 21, 2014 - TheStreet.com
4 Key Positive Biotech Stock Catalysts Coming Very Soon 2:10 p.m. July 17, 2014 - 247WallSt.com
12 Analyst Stocks to Buy Under $10 With Massive Upside Potential 8:36 a.m. July 12, 2014 - 247WallSt.com
Biggest Movers in Healthcare Stocks Now – HALO BKD ESC RDY 8:30 a.m. July 11, 2014 - InvestorPlace.com
Benzinga's Top Initiations 8:18 a.m. July 11, 2014 - benzinga.com
JP Morgan Initiates Halozyme Therapeutics With Outperform 6:54 a.m. July 11, 2014 - benzinga.com
Halozyme Attracting Attention With Upcoming Adcom And Potential Blockbuster Pancreatic Cancer Treatment 8:01 a.m. July 8, 2014 - Seeking Alpha
Halozyme's PEGPH20 Program In Metastatic Pancreatic Cancer Receives Fast Track Designation 8:30 a.m. Sept. 3, 2014 - PR Newswire - PRF
Expert Briefing on Biotech Stocks -- Nanosphere, Vanda Pharma, Synta Pharma, Halozyme Therapeutics, and Isis Pharma 9:30 a.m. Aug. 14, 2014 - PR Newswire - PRF
Halozyme to Host second Quarter 2014 Financial Results Conference Call 4:30 p.m. Aug. 4, 2014 - PR Newswire - PRF
FDA Advisory Committee Panel Provides Favorable Recommendation on Baxter’s HyQvia for Primary Immunodeficiency 1:55 p.m. July 31, 2014 - BusinessWire - BZX
Halozyme Resumes Patient Enrollment And Dosing In PEGPH20 Clinical Program In Pancreatic Cancer 9:00 a.m. July 22, 2014 - PR Newswire - PRF
Pre-market Equity Watch on Biotech Industry -- Research on Halozyme Therapeutics, XOMA, Amicus Therapeutics, and Arena Pharma 7:20 a.m. July 10, 2014 - PR Newswire - PRF
New Drug Applications, Agreements, Launches, and Appointments - Analyst Notes on Curis, Enzo Biochem, AGTC, Halozyme and Magellan Health 6:20 a.m. July 2, 2014 - PR Newswire - PRF
Roche's Commercial Launch Of MabThera SC Triggers Milestone Payment To Halozyme 8:00 a.m. June 25, 2014 - PR Newswire - PRF
Halozyme Therapeutics To Present At The JMP Securities 2014 Healthcare Conference 4:30 p.m. June 17, 2014 - PR Newswire - PRF
Halozyme Announces Presentation Of Clinical Data At The American Diabetes Association 74th Scientific Sessions 3:00 p.m. June 15, 2014 - PR Newswire - PRF
Biotech Equities under the Scanner -- Research on Halozyme Therapeutics, Medivation, Achillion Pharma, and Alexion Pharma 8:10 a.m. June 6, 2014 - PR Newswire - PRF
Halozyme To Resume PEGPH20 Clinical Program In Pancreatic Cancer 4:05 p.m. June 4, 2014 - PR Newswire - PRF
Halozyme Therapeutics To Present At The Jefferies 2014 Global Health Care Conference 4:30 p.m. May 29, 2014 - PR Newswire - PRF
Baxter Provides U.S. Regulatory Update on HyQvia,Its Investigational Subcutaneous Treatment for Primary Immunodeficiency 9:02 a.m. May 21, 2014 - BusinessWire - BZX
Earnings Release Results, and Leadership Appointments - Analyst Notes on Halozyme, MannKind, Arrowhead, Idera and BioCryst 7:00 a.m. May 16, 2014 - PR Newswire - PRF
Halozyme Therapeutics To Present At The UBS 2014 Global Health Care Conference 6:00 p.m. May 14, 2014 - PR Newswire - PRF
Top Gainers Pre-Market Notes -- Research on Halozyme Therapeutics, Goodrich Petroleum, BioCryst Pharma, and Coronado Biosciences 12:22 p.m. May 14, 2014 - PR Newswire - PRF
Halozyme Reports First Quarter 2014 Financial Results 4:15 p.m. May 12, 2014 - PR Newswire - PRF
Halozyme Therapeutics To Present At The Bank Of America Merrill Lynch 2014 Health Care Conference 4:30 p.m. May 7, 2014 - PR Newswire - PRF
Halozyme to Host first Quarter 2014 Financial Results Conference Call 5:00 p.m. May 5, 2014 - PR Newswire - PRF
Amazon gains on June event; PVH sinks on results 3:36 p.m. June 5, 2014 - Sue Chang
Stock futures rise after ECB moves, claims report 9:00 a.m. June 5, 2014 - Barbara Kollmeyer
ECB, jobs report could finally ignite the stock-market powder keg 8:46 a.m. June 5, 2014 - Shawn Langlois
PVH falls, Halozyme, Five Below, gain after hours 4:51 p.m. June 4, 2014 - Myra P. Saefong
Rackspace shares surge after hours on earnings 6:10 p.m. May 12, 2014 - Wallace Witkowski
Halozyme temporarily halts dosing in cancer study 9:27 a.m. April 4, 2014 - MarketWatch.com
A Morgan Stanley buy, Alcoa's report and the streaker opens up 8:18 a.m. Oct. 8, 2013 - Shawn Langlois
Halozyme shares jump on Roche $10 million milestone payment 12:40 p.m. Sept. 27, 2013 - Russ Britt
Isis, Novartis, Halozyme all rise on positive product news 11:48 a.m. Sept. 3, 2013 - Russ Britt
European regulators smile on small biotech Halozyme, and shares soar 6:22 p.m. June 28, 2013 - Russ Britt
Little-noticed firm makes a splash with pancreatic cancer treatment 2:25 p.m. May 16, 2013 - Russ Britt
6 gut checks before the stock market's opening bell 6:49 a.m. March 25, 2013 - Shawn Langlois
Synageva director bought shares for trust 2:41 p.m. Jan. 17, 2013 - Insider Monkey
Friday’s biggest gaining and declining stocks 4:51 p.m. Dec. 21, 2012 - Matt Andrejczak
ViroPharma gets okay to test reformulated Cinryze 1:09 p.m. Sept. 21, 2012 - MarketWatch.com
Halozyme soars 27% on Cinryze drug update 11:51 a.m. Sept. 21, 2012 - Val Brickates Kennedy
FDA lifts temporary hold on ViroPharma treatment 8:30 a.m. Sept. 21, 2012 - MarketWatch.com
Halozyme rebounds 12% in midday trading 11:21 a.m. Aug. 3, 2012 - Val Brickates Kennedy
Halozyme rebounds 10% in morning action 10:52 a.m. Aug. 3, 2012 - Val Brickates Kennedy
Halozyme's PEGPH20 Program Gains Fast Track Designation - Analyst Blog 5:00 p.m. Sept. 5, 2014 - Zacks.com
Hottest Healthcare Stocks Now – EXAS ACHN HALO CLDX 9:00 a.m. Sept. 3, 2014 - InvestorPlace.com
Halozyme's PEGPH20 Program In Metastatic Pancreatic Cancer Receives Fast Track Designation 7:35 a.m. Sept. 3, 2014 - benzinga.com
Halozyme Gains on Narrower-than-Expected Loss, Revenues Up - Analyst Blog 10:53 a.m. Aug. 14, 2014 - Zacks.com
Halozyme Therapeutics' (HALO) CEO Helen Torley on Q2 2014 Results - Earnings Call Transcript 6:50 p.m. Aug. 11, 2014 - Seeking Alpha
10-Q: HALOZYME THERAPEUTICS INC 4:32 p.m. Aug. 11, 2014 - Edgar Online - (EDG = 10Q, 10K)
Biggest Movers in Healthcare Stocks Now – IRWD IPXL SGEN PCRX 7:30 a.m. Aug. 6, 2014 - InvestorPlace.com
2nd Half Of 2014 Biotechnology Catalysts-Part 3 2:36 p.m. Aug. 4, 2014 - Seeking Alpha
Trade-Ideas: Halozyme Therapeutics (HALO) Is Today's "Perilous Reversal" Stock 10:47 a.m. Aug. 1, 2014 - TheStreet.com
Halozyme Therapeutics Receives Favorable FDA Decision 1:45 p.m. July 31, 2014 - benzinga.com
Biggest Movers in Healthcare Stocks Now – HALO TRNX LGND 1:45 p.m. July 31, 2014 - InvestorPlace.com
Biggest Movers in Healthcare Stocks Now – UTHR HLS HALO ARIA 7:45 a.m. July 29, 2014 - InvestorPlace.com
Halozyme Announces Resumption of Patient Enrollment, Dosing in PEGPH20 Clinical Trial 8:02 a.m. July 22, 2014 - benzinga.com
Trade-Ideas: Halozyme Therapeutics (HALO) Is Today's "Perilous Reversal" Stock 9:57 a.m. July 21, 2014 - TheStreet.com
4 Key Positive Biotech Stock Catalysts Coming Very Soon 2:10 p.m. July 17, 2014 - 247WallSt.com
12 Analyst Stocks to Buy Under $10 With Massive Upside Potential 8:36 a.m. July 12, 2014 - 247WallSt.com
Biggest Movers in Healthcare Stocks Now – HALO BKD ESC RDY 8:30 a.m. July 11, 2014 - InvestorPlace.com
Benzinga's Top Initiations 8:18 a.m. July 11, 2014 - benzinga.com
JP Morgan Initiates Halozyme Therapeutics With Outperform 6:54 a.m. July 11, 2014 - benzinga.com
Halozyme Attracting Attention With Upcoming Adcom And Potential Blockbuster Pancreatic Cancer Treatment 8:01 a.m. July 8, 2014 - Seeking Alpha
Halozyme's PEGPH20 Program In Metastatic Pancreatic Cancer Receives Fast Track Designation 8:30 a.m. Sept. 3, 2014 - PR Newswire - PRF
Expert Briefing on Biotech Stocks -- Nanosphere, Vanda Pharma, Synta Pharma, Halozyme Therapeutics, and Isis Pharma 9:30 a.m. Aug. 14, 2014 - PR Newswire - PRF
Halozyme to Host second Quarter 2014 Financial Results Conference Call 4:30 p.m. Aug. 4, 2014 - PR Newswire - PRF
FDA Advisory Committee Panel Provides Favorable Recommendation on Baxter’s HyQvia for Primary Immunodeficiency 1:55 p.m. July 31, 2014 - BusinessWire - BZX
Halozyme Resumes Patient Enrollment And Dosing In PEGPH20 Clinical Program In Pancreatic Cancer 9:00 a.m. July 22, 2014 - PR Newswire - PRF
Pre-market Equity Watch on Biotech Industry -- Research on Halozyme Therapeutics, XOMA, Amicus Therapeutics, and Arena Pharma 7:20 a.m. July 10, 2014 - PR Newswire - PRF
New Drug Applications, Agreements, Launches, and Appointments - Analyst Notes on Curis, Enzo Biochem, AGTC, Halozyme and Magellan Health 6:20 a.m. July 2, 2014 - PR Newswire - PRF
Roche's Commercial Launch Of MabThera SC Triggers Milestone Payment To Halozyme 8:00 a.m. June 25, 2014 - PR Newswire - PRF
Halozyme Therapeutics To Present At The JMP Securities 2014 Healthcare Conference 4:30 p.m. June 17, 2014 - PR Newswire - PRF
Halozyme Announces Presentation Of Clinical Data At The American Diabetes Association 74th Scientific Sessions 3:00 p.m. June 15, 2014 - PR Newswire - PRF
Biotech Equities under the Scanner -- Research on Halozyme Therapeutics, Medivation, Achillion Pharma, and Alexion Pharma 8:10 a.m. June 6, 2014 - PR Newswire - PRF
Halozyme To Resume PEGPH20 Clinical Program In Pancreatic Cancer 4:05 p.m. June 4, 2014 - PR Newswire - PRF
Halozyme Therapeutics To Present At The Jefferies 2014 Global Health Care Conference 4:30 p.m. May 29, 2014 - PR Newswire - PRF
Baxter Provides U.S. Regulatory Update on HyQvia,Its Investigational Subcutaneous Treatment for Primary Immunodeficiency 9:02 a.m. May 21, 2014 - BusinessWire - BZX
Earnings Release Results, and Leadership Appointments - Analyst Notes on Halozyme, MannKind, Arrowhead, Idera and BioCryst 7:00 a.m. May 16, 2014 - PR Newswire - PRF
Halozyme Therapeutics To Present At The UBS 2014 Global Health Care Conference 6:00 p.m. May 14, 2014 - PR Newswire - PRF
Top Gainers Pre-Market Notes -- Research on Halozyme Therapeutics, Goodrich Petroleum, BioCryst Pharma, and Coronado Biosciences 12:22 p.m. May 14, 2014 - PR Newswire - PRF
Halozyme Reports First Quarter 2014 Financial Results 4:15 p.m. May 12, 2014 - PR Newswire - PRF
Halozyme Therapeutics To Present At The Bank Of America Merrill Lynch 2014 Health Care Conference 4:30 p.m. May 7, 2014 - PR Newswire - PRF
Halozyme to Host first Quarter 2014 Financial Results Conference Call 5:00 p.m. May 5, 2014 - PR Newswire - PRF
(0)
(0)Scroll down for more posts ▼